“To provide menstruating patients with sickle cell disease the best care, primary care physicians, gynecologists, and ...

Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...

Doctors at Cleveland Clinic used a one-time gene editing cell therapy to modify Danielle’s own blood-forming stem cells to ...

Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

Key Takeaways U.S. emergency rooms aren’t providing prompt treatment for sickle cell pain crisisOnly 1 in 3 patients get ...

Administration of opioid medications to people who present to the ED with acute sickle cell disease pain often does not happen as quickly as guidelines recommend, data presented at ASH Annual Meeting ...

Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...

NHS England’s lead for sickle-cell services and Director of the National Healthcare Inequalities Improvement Programme, Dr ...

A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle ...

Guideline adherence for opioid pain medications was found to be suboptimal among patients with sickle cell disease pain in the ED.

A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle cell disease received appropriate opioid-based pain-relieving medications ...